Publications by authors named "Rodolfo Galindo"

Claim this Profile
C
Comparative Risk of Adverse Pancreatic Events With GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP4 Inhibitors, and Sulfonylureas Among Adults With Type 2 Diabetes at Moderate Cardiovascular Disease Risk.
Urja N Kalathiya, Jeph Herrin, Kavya Sindu Swarna, Yihong Deng, Eric C Polley, Rodolfo J Galindo

Endocr Pract· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology.
Ketan Dhatariya, Richard M Bergenstal, Mohammed Al-Sofiani, Anastasia Albanese-O'Neill, Tadej Battelino, Rodolfo J Galindo

Lancet Diabetes Endocrinol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Awareness of obesity's causes is not linked to less Weight-Related bias.
Albert Lecube, Rodolfo J Galindo, Blanca Salinas-Roca, Iñaki Marina, Andreea Ciudin

Sci Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of GLP-1 receptor agonists on cardiovascular outcomes among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target trial.
Stacey M Sklepinski, Yihong Deng, Kavya Sindu Swarna, Jeph Herrin, Eric C Polley, Rodolfo J Galindo

Diabetes Res Clin Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into the Mechanism of Action of Tirzepatide: A Narrative Review.
Rodolfo J Galindo, Alice Y Y Cheng, Christine Longuet, Minrong Ai, Tamer Coskun

Diabetes Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Importance of Expanding Medicare Continuous Glucose Monitoring Coverage for High-Risk Hypoglycemia.
Mary Elizabeth Patti, Grazia Aleppo, Davida Kruger, Carol J Levy, Jesse Bushman, Rodolfo J Galindo

Diabetes Technol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous Glucose Monitoring Improves Detection of Glycemic Excursions in Hemodialysis Patients With Type 2 Diabetes.
Rodolfo J Galindo, Bobak Moazzami, Amany Gerges, Ina Flores, Giuliana Arevalo

J Clin Endocrinol Metab· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in body mass index category was associated with improved cardiometabolic measures and patient-reported outcomes in adults with type 2 diabetes treated with tirzepatide.
Rodolfo J Galindo, Clare J Lee, Sheryl Elaine Allen, Anne Dib, Kristina S Boye

Diabetes Obes Metab· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescribing Trends of Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes or Obesity.
Piaopiao Li, Jithin S Varghese, Megha K Shah, Rodolfo J Galindo, Francisco J Pasquel

JAMA Netw Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wearable Diabetes Technology for Hospitalized People With Diabetes and End-Stage Kidney Disease, Peripartum State, and Steroid Use.
Shubham Agarwal, Andrew P Demidowich, Diana Soliman, Guillermo E Umpierrez, Rodolfo J Galindo

J Diabetes Sci Technol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous Glucose Monitoring for Prediabetes: Roles, Evidence, and Gaps.
Salwa J Zahalka, Halis K Akturk, Rodolfo J Galindo, Viral N Shah, Cecilia C Low Wang

Endocr Pract· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving Beyond Glycated Hemoglobin to Glucose Patterns: Newer Indications for Continuous Glucose Monitor Use.
Shubham Agarwal, Ron T Varghese, Renato Savian, Cecilia C Low Wang, Rodolfo J Galindo

Endocr Pract· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Sight-Threatening Diabetic Retinopathy with Glucagon-Like Peptide-1 Receptor Agonist Use in Routine Clinical Practice: Comparative Effectiveness of Semaglutide, Dulaglutide, Liraglutide, and Exenatide.
Andrew J Barkmeier, Yihong Deng, Kavya Sindhu Swarna, Jeph Herrin, Eric C Polley, Rodolfo J Galindo

Ophthalmol Retina· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technology Advancements and Persistent Challenges in Type 1 Diabetes.
Diana Soliman, Rodolfo J Galindo, Ashby F Walker

JAMA Netw Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing the Diabetes Tsunami Requires Expanded Access to Diabetes Technologies.
Davida F Kruger, Christopher G Parkin, Irl B Hirsch, Grazia Aleppo, Janet B McGill, Rodolfo J Galindo

J Diabetes Sci Technol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of advanced technologies in improving diabetes outcomes.
David G Marrero, Christopher G Parkin, Grazia Aleppo, Irl B Hirsch, Janet McGill, Rodolfo J Galindo

Am J Manag Care· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in Patients With Type 2 Diabetes After Hospital Discharge.
Guillermo E Umpierrez, Iris Castro-Revoredo, Bobak Moazzami, Irina Nayberg, Zohyra Zabala, Rodolfo J Galindo

Endocr Pract· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1RA Use and Thyroid Cancer Risk.
Juan P Brito, Jeph Herrin, Kavya Sindhu Swarna, Naykky M Singh Ospina, Victor M Montori, Rodolfo J Galindo

JAMA Otolaryngol Head Neck Surg· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Comments on Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes Care 2024;47:1257-1275.
Guillermo E Umpierrez, Georgia M Davis, Nuha ElSayed, Gian Paolo Fadini, Rodolfo J Galindo

Diabetes Care· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing obesity in adults with type 1 diabetes.
Alejandro Campos, Rene Rivera Gutierrez, Rodolfo J Galindo, Rozalina G McCoy, Maria D Hurtado Andrade

Diabetes Res Clin Pract· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without Diabetes.
Nicole L Spartano, Brenton Prescott, Maura E Walker, Eleanor Shi, Guhan Venkatesan, Rodolfo J Galindo

J Diabetes Sci Technol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes and Glucose Management in People on Hemodialysis.
Shubham Agarwal, Julia K Mader, Giuliana Arevalo, Sreekant Avula, Efren Chavez, Rodolfo J Galindo

Diabetes Spectr· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus Report on the Use of Continuous Glucose Monitoring in Chronic Kidney Disease and Diabetes.
Connie M Rhee, Roma Y Gianchandani, David Kerr, Athena Philis-Tsimikas, Csaba P Kovesdy, Rodolfo J Galindo

J Diabetes Sci Technol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors.
David C Klonoff, Guido Freckmann, Stefan Pleus, Boris P Kovatchev, David Kerr, Rodolfo J Galindo

J Diabetes Sci Technol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney Outcomes with Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes and Moderate Cardiovascular Risk.
Joshua J Neumiller, Jeph Herrin, Kavya Sindhu Swarna, Eric C Polley, Rodolfo J Galindo

Clin J Am Soc Nephrol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis